PT  - JOURNAL ARTICLE
AU  - Joshua A. Salomon
AU  - Alex Reinhart
AU  - Alyssa Bilinski
AU  - Eu Jing Chua
AU  - Wichada La Motte-Kerr
AU  - Minttu M. Rönn
AU  - Marissa Reitsma
AU  - Katherine Ann Morris
AU  - Sarah LaRocca
AU  - Tamar Farag
AU  - Frauke Kreuter
AU  - Roni Rosenfeld
AU  - Ryan J. Tibshirani
TI  - The U.S. COVID-19 Trends and Impact Survey, 2020-2021: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing and vaccination
AID  - 10.1101/2021.07.24.21261076
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.24.21261076
4099  - http://medrxiv.org/content/early/2021/07/26/2021.07.24.21261076.short
4100  - http://medrxiv.org/content/early/2021/07/26/2021.07.24.21261076.full
AB  - The U.S. COVID-19 Trends and Impact Survey (CTIS) is a large, cross-sectional, Internet-based survey that has operated continuously since April 6, 2020. By inviting a random sample of Facebook active users each day, CTIS collects information about COVID-19 symptoms, risks, mitigating behaviors, mental health, testing, vaccination, and other key priorities. The large scale of the survey – over 20 million responses in its first year of operation – allows tracking of trends over short timescales and allows comparisons at fine demographic and geographic detail. The survey has been repeatedly revised to respond to emerging public health priorities. In this paper, we describe the survey methods and content and give examples of CTIS results that illuminate key patterns and trends and help answer high-priority policy questions relevant to the COVID-19 epidemic and response. These results demonstrate how large online surveys can provide continuous, real-time indicators of important outcomes that are not subject to public health reporting delays and backlogs. The CTIS offers high value as a supplement to official reporting data by supplying essential information about behaviors, attitudes toward policy and preventive measures, economic impacts, and other topics not reported in public health surveillance systems.Significance statement The U.S. COVID-19 Trends and Impact Survey (CTIS) has operated continuously since April 6, 2020, collecting over 20 million responses. The largest public health survey ever conducted in the United States, CTIS was designed to facilitate detailed demographic and geographic analyses, track trends over time, and accommodate rapid response to emerging priorities. Using examples of CTIS results illuminating trends in symptoms, risks, mitigating behaviors, testing and vaccination in relation to evolving high-priority policy questions over 12 months of the pandemic, we illustrate the value of online surveys for tracking patterns and trends in COVID outcomes as an adjunct to official reporting, and showcase unique insights that would not be visible through traditional public health reporting.Competing Interest StatementThis material is based on work supported by gifts from Facebook, Google.org, and grants from the Centers for Disease Control and Prevention.Funding StatementThis material is based on work supported by gifts from Facebook, Google.org, and grants from the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Carnegie Mellon University Institutional Review Board, under protocol STUDY2020_00000162All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregate data from the U.S. CTIS survey are available via the COVIDcast API, and individual data are available to researchers, subject to privacy restrictions, through data use agreement. https://cmu-delphi.github.io/delphi-epidata/symptom-survey/